Emergent Biosolutions CEO Robert Kramer told CNBC Monday it is uncertain that a coronavirus vaccine can be available by the end of the year to fulfill President Donald Trump’s wishes.
The specialty biopharmaceutical company is collaborating with drug giant Johnson & Johnson on a Covid-19 vaccine candidate, which Johnson & Johnson hopes will receive emergency use authorization in 2021.
{iframe}https://www.cnbc.com/2020/05/04/emergent-biosolutions-ceo-no-guarantee-vaccine-will-be-ready-this-year.html{/iframe}